1. The management of iron overload in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients: Where do we stand?

   • Serdar Sivgin
   • Bulent Eser

   Review Article 22 February 2013 Pages: 577 - 586

2. Morphology and quantitative composition of hematopoietic cells in murine bone marrow and spleen of healthy subjects

   • Min Yang
   • Guntram Büsche
   • Zhixiong Li

   Original Article 10 January 2013 Pages: 587 - 594

   

3. Cytological characterization of murine bone marrow and spleen hematopoietic compartments for improved assessment of toxicity in preclinical gene marking models

   • Min Yang
   • Guntram Büsche
   • Zhixiong Li

   Original Article 10 January 2013 Pages: 595 - 604

   

4. Hematological abnormalities in severe anorexia nervosa

   • Allison L. Sabel
   • Jennifer L. Gaudiani
   • Philip S. Mehler

   Original Article 08 February 2013 Pages: 605 - 613

   

5. Association of vitamin D deficiency and anemia in a hospitalized geriatric population: denutrition as a confounding factor

   • A. Coutard
   • R. Garlantézec
   • A. Gentric

   Original Article 16 December 2012 Pages: 615 - 619

6. High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM

   • C. Kelaidi
   • O. Beyne-Rauzy
   • P. Fenaux

   Original Article 29 January 2013 Pages: 621 - 631

   

7. Erratum to: High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM

   • C. Kelaidi
   • O. Beyne-Rauzy
   • P. Fenaux

   Erratum 06 March 2013 Pages: 633 - 633

8. Gene mutation profiles and prognostic implications in Korean patients with T-lymphoblastic leukemia

   • Hee Jae Huh
   • Soo Hyun Lee
   • Hee-Jin Kim

   Original Article 25 January 2013 Pages: 635 - 644

   

9. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia

   • Guibo Ma
   • Fang Liu
   • Yanhua Su

   Original Article 24 January 2013 Pages: 645 - 652

   

10. Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia

    • Norbert Niederle
    • Dirk Megdenberg
    • Hartmut Eimermacher

    Original Article 23 January 2013 Pages: 653 - 660

    

11. Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases

    • Lev Shvidel
    • Tamar Tadmor
    • on behalf of the Israeli CLL Study Group (ICLLSG)

    Original Article 29 December 2012 Pages: 661 - 667

    

12. Tumor-associated macrophages as a prognostic parameter in multiple myeloma

    • Elif Suyanı
    • Gülsan Türköz Sucak
    • Rauf Haznedar

    Original Article 20 January 2013 Pages: 669 - 677

    

13. Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens

    • Qi-Fa Liu
    • Zhi-Ping Fan
    • Fan-Yi Meng

    Original Article 30 December 2012 Pages: 679 - 687

    

14. Prophylaxis and quality of life in patients with hemophilia A during routine treatment with ADVATE [antihemophilic factor (recombinant), plasma/albumin-free method] in Germany: a subgroup analysis of the ADVATE PASS post-approval, non-interventional study

    • Hartmut Pollmann
    • Robert Klamroth
    • Johannes Oldenburg

    Original Article 17 January 2013 Pages: 689 - 698

    

15. Outcome of critically ill patients with hematological malignancies

    • Silvio A. Ñamendys-Silva
    • María O. González-Herrera
    • Angel Herrera-Gómez

    Original Article 18 January 2013 Pages: 699 - 705

    

16. Erythroleukemia showing early erythroid and cytogenetic responses to azacitidine therapy

    • Sho Hangai
    • Fumihiko Nakamura
    • Mineo Kurokawa

    Letter to the Editor 16 October 2012 Pages: 707 - 709

    

17. Splenectomy followed by administration of rituximab is useful to treat a patient with hairy cell leukemia-variant

    • Tetsumi Yoshida
    • Keichiro Mihara
    • Yoshihiro Takihara

    Letter to the Editor 25 November 2012 Pages: 711 - 713

    

18. New missense homozygous mutation (Q270Ter) in the pyrimidine 5′ nucleotidase type I-related gene in two Indian families with hereditary non-spherocytic hemolytic anemia

    • Prashant Warang
    • Prabhakar Kedar
    • Roshan Colah

    Letter to the Editor 09 November 2012 Pages: 715 - 717